Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Pakistan
  4. The Pakistan Stock Exchange
  5. Abbott Laboratories (Pakistan) Limited
  6. Summary
    ABOT   PK0025701019

ABBOTT LABORATORIES (PAKISTAN) LIMITED

(ABOT)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote The Pakistan Stock Exchan…
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
762.37 753.15 741.46 788.72 780.59 Last
8050 12600 84200 13950 30300 Volume
+0.15% -1.21% -1.55% +6.37% -1.03% Change
Estimated financial data (e)
Sales 2021 41 891 M 248 M 248 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 6,41%
Sales 2022 47 127 M 279 M 279 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 7,05%
Capitalization 76 420 M 452 M 452 M
Capi. / Sales 2021 1,82x
Capi. / Sales 2022 1,62x
Nbr of Employees 1 464
Free-Float 18,6%
More Financials
Company
Abbott Laboratories (Pakistan) Limited is a Pakistan-based healthcare company. The Company is engaged in the manufacture, import and marketing of research-based pharmaceutical, nutritional, diagnostic, diabetic care, hospital and consumer products. The Company's segments include Pharmaceutical, Nutritional and Others. The Pharmaceutical segment is engaged in the manufacture, import and marketing of research-based... 
Read more
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about ABBOTT LABORATORIES (PAKISTAN) LIMITED
09/08ABBOTT LABORATORIES (PAKISTAN) LIMIT : Ex-dividend day for interim dividend
FA
08/27Abbott Laboratories Pakistan Limited Reports Earnings Results for the Second Quarter En..
CI
04/23Abbott Laboratories Pakistan Limited Reports Earnings Results for the First Quarter End..
CI
04/12ABBOTT LABORATORIES (PAKISTAN) LIMIT : Ex-dividend day for final dividend
FA
02/26Abbott Laboratories Limited Reports Earnings Results for the Full Year Ended December 3..
CI
2020Abbott Laboratories Pakistan Limited Reports Earnings Results for the Third Quarter End..
CI
2020ABBOTT LABORATORIES (PAKISTAN) LIMIT : Ex-dividend day for interim dividend
FA
2020Abbott Laboratories Pakistan Limited Reports Earnings Results for the Second Quarter En..
CI
2020Credit of Final Cash Dividend of Abbott Laboratories Limited
AQ
2020Transaction of 7,000 shares of Attock Cement Pakistan Limited
AQ
2020Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbott Laborato..
AQ
2020Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbott Laborato..
AQ
2020Re-appointment of Chief Executive of Abbott Laboratories Limited
AQ
2020Re-appointment of Chairman of Abbott Laboratories Limited
AQ
2020Financial results of Abbott Laboratories Limited for Quarter ended March 31, 2020
AQ
More news
News in other languages on ABBOTT LABORATORIES (PAKISTAN) LIMITED

- No features available -

More news
Chart ABBOTT LABORATORIES (PAKISTAN) LIMITED
Duration : Period :
Abbott Laboratories (Pakistan) Limited Technical Analysis Chart | ABOT | PK0025701019 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES (PAKISTAN) LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 780,59 PKR
Average target price 920,00 PKR
Spread / Average Target 17,9%
Managers and Directors
Syed Anis Ahmed Chief Executive Officer & Executive Director
Syed Tabish Aseem Chief Financial Officer
Munir Ahmad Shaikh Chairman
Raeef Ahmed Director-Medical Affairs
Ihsan Ullah Khan Khattak Operations Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES (PAKISTAN) LIMITED3.34%452
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037